FDA public hearing
This article was originally published in The Tan Sheet
FDA plans a Dec. 18 public hearing on issues concerning the electronic submission of product information, the agency announces in a Federal Register 1notice slated for publication Nov. 21. The hearing will cover feasibility issues related to the electronic submission of premarket applications, other regulatory information such as postmarketing information, and issues related to the concept and feasibility of an electronic platform, FDA says. Comments and requests to speak at the hearing are due to FDA by Dec. 8...
You may also be interested in...
The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.
No device-related warning letters were released by the US FDA the week of 26 January.
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.